Showing results (611-620 of 629) with videos related to

Sort By:
Pageof 63
Vaccine|May 24, 2020
Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western KenyaM Oneko, Y R Cherop, T Sang, et al.
The Lancet. Global Health|September 20, 2025
Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trialLawrence Osei-Tutu, Simon K Kariuki, Cynthia K Lee, et al.
Emerging Infectious Diseases|November 21, 2017
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa NetworkEric S Halsey, Meera Venkatesan, Mateusz M Plucinski, et al.
The Journal of Infectious Diseases|March 4, 2024
Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria VaccineNelli Westercamp, Lawrence Osei-Tutu, Lode Schuerman, et al.
Lancet (London, England)|April 7, 2024
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and MalawiKwaku Poku Asante, Don P Mathanga, Paul Milligan, et al.
Emerging Infectious Diseases|June 21, 2021
Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014-2018Sarah E Schmedes, Dhruviben Patel, Simran Dhal, et al.
The Lancet. Infectious Diseases|June 26, 2022
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trialAaron M Samuels, Daniel Ansong, Simon K Kariuki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2019
Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western KenyaLaura C Steinhardt, Thomas L Richie, Reuben Yego, et al.
Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The Lancet. Infectious Diseases|May 9, 2024
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trialMichal Juraska, Angela M Early, Li Li, et al.
Pageof 63